AMPLY Discovery
About AMPLY Discovery
AMPLY Discovery is a Diagnostics startup based in Seoul, South Koreasince 2024. The company reached Seed stage in July 2026 with a null round led by institutional investors. AMPLY Discovery's investor base includes 1 institutional fund, with its lead investor leading the most recent equity round.
AMPLY is a Seoul-based bio AI startup developing everyday health diagnostics through its proprietary Triple-S platform, built on nanobio research from Yonsei University. Its technologies — A-cube (ultra-high-sensitivity bio AI) and Amp.Vision (deep learning quantitative analysis) — achieve up to 99% reading accuracy across a range of point-of-care self-test kits. The company commercialises its diagnostics through its consumer brand Winti, offering products for nutrition monitoring, skin health, and fertility testing.
AMPLY Discovery Funding Rounds Timeline
1 rounds · since 2024
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Seed | July 2026 | Undisclosed | — | — | Bluepoint Partners |
Investors in AMPLY Discovery
1 institutional investors across 1 rounds
Co-investors
Recent news about AMPLY Discovery
Questions about AMPLY Discovery
How much has AMPLY Discovery raised?
AMPLY Discovery has raised null across 1 funding round since 2024.
Who are the investors of AMPLY Discovery?
AMPLY Discovery's investors include Bluepoint Partners.
When was AMPLY Discovery's last funding round?
AMPLY Discovery's most recent round was a null Seed in July 2026.
Where is AMPLY Discovery headquartered?
AMPLY Discovery is headquartered in Seoul, South Korea, and was founded in 2024 by Junmin Kim.